The Drug Delivery Company, LLC is a pharmaceutical company based in Salisbury, MD, specializing in sustained release drug delivery. With their innovative Implantable Subcutaneous Tunable Extended-release Polymeric implant (ISTEP-N), they aim to provide a versatile and effective solution for delivering pharmaceutical agents that would otherwise require injections. Their six-month duration drug delivery system offers an excellent choice for medications where compliance is a challenge.
Akyso's ISTEP-N implant is currently under development and will soon enter human trials. The company's research and development team has extensive experience in in vitro and in vivo studies, as well as surgery and instrument design. Led by Dr. Jeffrey Benner, a practicing physician and retinal specialist, Akyso is committed to addressing the opioid crisis and improving treatment options for opioid use disorder, with the potential for expanding their implant technology to other addiction disorders in the future.
Generated from the website